Sutro Biopharma, Inc

(NASDAQ:STRO)

Latest On Sutro Biopharma, Inc (STRO):

Date/Time Type Description Signal Details
2023-05-15 15:17 ESTNewsSutro Biopharma GAAP EPS of -$0.85, revenue of $12.7MN/A
2023-05-03 15:49 ESTNewsSutro, Mersana jump after Immunogen data for ovarian cancer therapyN/A
2023-04-11 19:04 ESTNewsSutro: Too Little, Too Late For STRO-002, But Platform Is InterestingN/A
2023-03-31 10:48 ESTNewsSutro Biopharma GAAP EPS of -$2.35 beats by $0.16, revenue of $67.8M misses by $0.57MN/A
2023-03-22 01:51 ESTNewsSutro Biopharma stock slides as transferred to Equal Weight at Wells FargoN/A
2023-02-28 10:05 ESTNewsSutro Biopharma appoints Borgman as Chief Medical OfficerN/A
2022-12-20 18:43 ESTNewsVaxcyte acquires option from Sutro Biopharma to expand rights to make cell-free extractN/A
2022-11-08 19:34 ESTNewsSutro Biopharma GAAP EPS of -$0.37 misses by $0.08, revenue of $25.14M misses by $10.62MN/A
2022-08-16 14:27 ESTNewsSutro Biopharma: Partnership Progress Warrants ExposureN/A
2022-08-09 08:23 ESTNewsSutro Biopharma GAAP EPS of -$0.55, revenue of $28.1MN/A
2022-07-26 21:24 ESTNewsSutro to get $10M payment from Merck after first patient dosed in collaboration trialN/A
2022-06-28 10:31 ESTNewsSutro Biopharma soars ~50% after announcing worldwide strategic collaboration with Astellas PharmaN/A
2022-05-09 17:15 ESTNewsSutro Biopharma GAAP EPS of -$0.84 misses by $0.08, revenue of $5.89M misses by $4.57MN/A
2022-02-28 19:19 ESTNewsSutro Biopharma GAAP EPS of -$2.29 misses by $0.13, revenue of $61.88M beats by $0.16MN/A
2022-01-06 18:39 ESTNewsSutro at a 52-week low as analysts weigh in on safety data for cancer drugN/A
2022-01-06 02:58 ESTNewsSutro posts early-stage data for ovarian cancer drug indicating 33% ORRN/A
2021-12-27 20:30 ESTNewsSutro Bio inks licensing deal for STRO-002 in Greater ChinaN/A
2021-12-27 20:30 ESTNewsSutro; A Biotech To Watch With A Catalyst Rapidly ApproachingN/A
2021-12-06 22:52 ESTNewsSutro Biopharma (STRO) Presents At 4th Annual Evercore ISI HealthCONx Conference - SlideshowN/A
2021-12-06 22:52 ESTNewsSutro Biopharma (STRO) Presents At Piper Sandler 33rd Annual Virtual Healthcare Conference - SlideshowN/A
2021-12-06 22:52 ESTNewsSutro Biopharma (STRO) Presents At Jefferies London Healthcare Conference - SlideshowN/A
2021-11-23 08:45 ESTNewsSutro Biopharma (STRO) Presents At 2021 Virtual Healthcare Conference - SlideshowN/A
2021-11-10 16:26 ESTNewsSutro Biopharma EPS misses by $0.02, misses on revenueN/A
2021-10-12 13:29 ESTNewsSutro Biopharma and BioNova ink collaboration agreement for STRO-001 in Greater ChinaN/A
2021-10-01 22:07 ESTNewsSutro Biopharma and Merck extend research term for cytokine derivative programN/A
2021-09-11 04:32 ESTNewsSutro Biopharma (STRO) Presents At 2021 Virtual Wells Fargo Healthcare ConferenceN/A
2021-08-18 17:50 ESTNewsSutro Biopharma nabs FDA Fast Track Designation for ovarian cancer therapyN/A
2021-08-09 15:28 ESTNewsSutro Biopharma reports Q2 resultsN/A
2021-07-22 02:42 ESTNewsSutro Biopharma initiated buy at H.C. Wainwright citing ADC candidatesN/A
2021-05-07 16:03 ESTNewsSutro Biopharma EPS misses by $0.04, beats on revenueN/A
2021-04-16 02:20 ESTNewsSutro Biopharma (STRO) Presents At 20th Annual Needham Virtual Healthcare Conference - SlideshowN/A
2021-04-15 08:22 ESTNewsSutro Biopharma earns milestone payment from Merck collaborationN/A
2021-03-19 02:57 ESTNewsSutro Biopharma EPS misses by $1.07, revenue in-lineN/A
2021-03-03 12:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.14 to $29.43.Neutral
2021-02-24 14:49 ESTNewsBristol-Myers receives FDA’s orphan drug designation for multiple myeloma therapyN/A
2021-01-29 08:37 ESTAnalyst RatingThe Analyst Target Price has increased from $29.29 to $31.14.Buy
2021-01-22 08:39 ESTAnalyst RatingThe Analyst Target Price has increased from $28.57 to $29.29.Buy
2021-01-21 14:56 ESTNewsDosing underway in Sutro Biopharma's early-stage ovarian cancer trial with STRO-002N/A
2021-01-06 11:06 ESTNewsSutro: Leading Cell Free Protein Synthesis Company With Promising Early DataN/A
2020-12-15 13:03 ESTAnalyst RatingThe Analyst Target Price has increased from $27.57 to $28.57.Buy
2020-12-11 12:45 ESTAnalyst RatingThe Analyst Target Price has increased from $26.86 to $27.57.Buy
2020-12-09 07:03 ESTNewsSutro Biopharma (STRO) Investor Presentation - SlideshowN/A
2020-12-09 07:03 ESTNewsSutro Biopharma prices $126M public offeringN/A
2020-12-08 12:46 ESTNewsSutro Biopharma down after STRO-001 data in blood cancer studyN/A
2020-12-08 12:46 ESTNewsSutro Biopharma -4.6% after filing to offer 5M sharesN/A
2020-12-07 21:12 ESTAnalyst RatingThe Analyst Target Price has increased from $21.57 to $26.86.Buy
2020-12-04 12:27 ESTNewsSutro +23.5% as ovarian cancer drug study offers encouraging interim dataN/A
2020-12-04 09:03 ESTAnalyst RatingThe Analyst Target Price has increased from $21 to $21.57.Neutral
2020-11-28 06:08 ESTNewsSeeking Alpha Catalyst WatchN/A
2020-11-26 21:40 ESTFinancialsCompany financials have been released.Neutral

About Sutro Biopharma, Inc (STRO):

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers. It has collaboration and license agreement with Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

STRO Quotes by TradingView

See Advanced Chart

General

  • Name Sutro Biopharma, Inc
  • Symbol STRO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 182
  • Fiscal Year EndDecember
  • IPO Date2018-09-27
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.sutrobio.com
View More

Valuation

  • Trailing PE 54.26
  • Price/Sales (Trailing 12 Mt.) 14.95
  • Price/Book (Most Recent Quarter) 4.48
  • Enterprise Value Revenue 18.27
  • Enterprise Value EBITDA 41.71
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.56
  • Profit Margin 28%
  • Operating Margin -134%
  • Return on Assets -16%
  • Return on Equity 7%
  • Revenue 45.75 million
  • Earnings Per Share $0.44
  • Revenue Per Share $1.62
  • Gross Profit -22876000
  • Quarterly Earnings Growth 45.2%
View More

Highlights

  • Market Capitalization 1.09 billion
  • EBITDA -36933000
  • PE Ratio -3.01
  • Analyst Target Price $29.43
  • Book Value Per Share $6.41
View More

Share Statistics

  • Shares Outstanding 45.61 million
  • Shares Float 34.47 million
  • % Held by Insiders 1111%
  • % Held by Institutions 88.44%
  • Shares Short 1.14 million
  • Shares Short Prior Month 1.03 million
  • Short Ratio 2.56
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 0.79
  • 52 Week High $28.3
  • 52 Week Low $6.91
  • 50 Day Moving Average 23.26
  • 200 Day Moving Average 18.4
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Sutro Biopharma, Inc (STRO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Sutro Biopharma, Inc (STRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$17.82 million$0.45-$0.51188.74%
2020-06-302020-08-06$N/A$0.94-$0.64246.01%
2020-03-312020-05-11$7.15 million-$0.84-$0.69-21.99%
2019-12-312020-03-16$11.31 million-$0.64-$0.697.81%
2019-09-302019-11-08$12.28 million-$0.56-$0.6514.45%
2019-06-302019-08-14$10.53 million-$0.60-$0.623.41%
2019-03-312019-05-15$8.63 million-$0.62-$0.61-2.06%
2018-12-312018-12-31$19.09 million-$0.26-$0.6358.73%
2018-09-302018-11-14$7.84 million-$0.45-$0.8547.5%

Sutro Biopharma, Inc (STRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Sutro Biopharma, Inc (STRO) Chart:

Sutro Biopharma, Inc (STRO) News:

Below you will find a list of latest news for Sutro Biopharma, Inc (STRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sutro Biopharma, Inc (STRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-03-202.50CALL0 00TRUE00
2026-03-2050CALL0 01182.96TRUE00
2026-03-207.50CALL0 0990.84TRUE00
2026-03-20100CALL0 0698.62TRUE00
2026-03-2012.511CALL0 1498.31TRUE00
2026-03-20152.25CALL0 5373.19TRUE00
2026-03-2017.55.8CALL0 1354.04TRUE00
2026-03-20202.1CALL0 19250.08TRUE00
2026-03-2022.50CALL0 0286.58TRUE00
2026-03-20250CALL0 0688.92FALSE00
2026-03-20300CALL0 0854.83FALSE00
2026-03-202.50PUT0 00FALSE00
2026-03-2050.01PUT0 10805.75FALSE00
2026-03-207.50.01PUT0 101598.7FALSE00
2026-03-20100PUT0 00FALSE00
2026-03-2012.50.1PUT0 290767.81FALSE00
2026-03-20150.75PUT0 1341294.27FALSE00
2026-03-2017.50.2PUT0 901041.97FALSE00
2026-03-20200.3PUT0 35826.66FALSE00
2026-03-2022.51.26PUT0 6393.53FALSE00
2026-03-20250PUT0 0163.34TRUE00
2026-03-20306PUT0 100TRUE00
2026-04-172.50CALL0 0622.57TRUE00
2026-04-1750CALL0 0411.96TRUE00
2026-04-177.50CALL0 0270.46TRUE00
2026-04-17100CALL0 0252.33TRUE00
2026-04-1712.50CALL0 0190.11TRUE00
2026-04-17150CALL0 0148.1TRUE00
2026-04-1717.50CALL0 0142.66TRUE00
2026-04-17200CALL0 0132.87TRUE00
2026-04-1722.50CALL0 2123.56TRUE00
2026-04-17254.2CALL0 2132.36FALSE00
2026-04-17300CALL0 0174.36FALSE00
2026-04-17350.45CALL1 0113.4FALSE0.450
2026-04-172.50PUT0 00FALSE00
2026-04-1750PUT0 00FALSE00
2026-04-177.50.1PUT0 20862.1FALSE00
2026-04-17100.1PUT0 10637.92FALSE00
2026-04-1712.50.2PUT37 173139.75FALSE0.20
2026-04-17150.5PUT0 3403.94FALSE00
2026-04-1717.50.8PUT0 1325.41FALSE00
2026-04-17200PUT0 0258.43FALSE00
2026-04-1722.50PUT0 0104.35FALSE00
2026-04-17250PUT0 085.37TRUE00
2026-04-17300PUT0 070.61TRUE00
2026-04-17350PUT0 00TRUE00
2026-05-152.50.2CALL0 0378.54TRUE00
2026-05-1550CALL0 0252.39TRUE00
2026-05-157.53CALL0 1219.46TRUE00
2026-05-15100CALL0 0181.01TRUE00
2026-05-1512.54.2CALL0 4146.13TRUE00
2026-05-15154CALL0 3148.1TRUE00
2026-05-1517.50CALL0 1140TRUE00
2026-05-15203.8CALL0 3128.39TRUE00
2026-05-1522.56.2CALL0 2118.34TRUE00
2026-05-15251.15CALL0 1115.68FALSE00
2026-05-15300CALL0 0127.26FALSE00
2026-05-15350CALL0 0219.37FALSE00
2026-05-152.50.05PUT0 10FALSE00
2026-05-1550PUT0 01322.28FALSE00
2026-05-157.50.25PUT0 140178.35FALSE00
2026-05-15100.75PUT0 14219.1FALSE00
2026-05-1512.50.6PUT0 376163.98FALSE00
2026-05-15151PUT0 4293.74FALSE00
2026-05-1517.50PUT0 1150.41FALSE00
2026-05-15201.95PUT0 2118.95FALSE00
2026-05-1522.50PUT0 098.87FALSE00
2026-05-15250PUT0 097.19TRUE00
2026-05-15300PUT0 086.75TRUE00
2026-05-15350PUT0 087.99TRUE00
2026-08-212.514.32CALL0 1228.29TRUE00
2026-08-2150CALL0 0173.12TRUE00
2026-08-217.50CALL0 0147.78TRUE00
2026-08-21109.06CALL0 3144.62TRUE00
2026-08-2112.50CALL0 0129.11TRUE00
2026-08-211512.49CALL0 2123.27TRUE00
2026-08-2117.55.1CALL0 4124.88TRUE00
2026-08-21204.05CALL0 15120.72TRUE00
2026-08-2122.57.47CALL0 1119.07TRUE00
2026-08-21252.85CALL0 2111.88FALSE00
2026-08-21305.3CALL0 4109.67FALSE00
2026-08-21353.72CALL0 2109.93FALSE00
2026-08-212.50PUT0 00FALSE00
2026-08-2150PUT0 0849.23FALSE00
2026-08-217.50PUT0 0387.5FALSE00
2026-08-21101.6PUT0 2286.66FALSE00
2026-08-2112.52.45PUT0 4225.97FALSE00
2026-08-21150PUT0 0119.63FALSE00
2026-08-2117.50PUT0 0110.35FALSE00
2026-08-21200PUT0 0107.48FALSE00
2026-08-2122.50PUT0 0105.59FALSE00
2026-08-212511.58PUT0 1103.89TRUE00
2026-08-21300PUT0 0104.42TRUE00
2026-08-21350PUT0 0101.75TRUE00

Latest STRO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST220$3.585
Jun 13, 2022 7:59 PM EST84$3.585
Jun 13, 2022 7:59 PM EST100$3.585
Jun 13, 2022 7:59 PM EST65$3.585
Jun 13, 2022 7:59 PM EST10$3.585

Sutro Biopharma, Inc (STRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm
2019-10-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1382101/000000000019014405/0000000000-19-014405-index.htm
2020-05-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000092189520001581/0000921895-20-001581-index.htm
2020-08-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000093583620000485/0000935836-20-000485-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000110465918059933/0001104659-18-059933-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000110465918060241/0001104659-18-060241-index.htm
2018-10-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465918060573/0001104659-18-060573-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920013796/0001104659-20-013796-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920019043/0001104659-20-019043-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920020195/0001104659-20-020195-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920021714/0001104659-20-021714-index.htm
2020-08-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920098064/0001104659-20-098064-index.htm
2018-10-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420418052437/0001144204-18-052437-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420419006659/0001144204-19-006659-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420419008119/0001144204-19-008119-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420419008329/0001144204-19-008329-index.htm
2018-10-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1382101/000119312518295955/0001193125-18-295955-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000119312518322690/0001193125-18-322690-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000119312518326967/0001193125-18-326967-index.htm
2019-10-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1382101/000119312519262726/0001193125-19-262726-index.htm
2019-10-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1382101/000119312519265124/0001193125-19-265124-index.htm
2019-10-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1382101/000119312519266765/0001193125-19-266765-index.htm
2020-05-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1382101/000119312520139053/0001193125-20-139053-index.htm
2020-05-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1382101/000119312520140570/0001193125-20-140570-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052480/0001209191-18-052480-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052481/0001209191-18-052481-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052482/0001209191-18-052482-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052483/0001209191-18-052483-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052487/0001209191-18-052487-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052490/0001209191-18-052490-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052491/0001209191-18-052491-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052492/0001209191-18-052492-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052493/0001209191-18-052493-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052495/0001209191-18-052495-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052496/0001209191-18-052496-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052826/0001209191-18-052826-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052831/0001209191-18-052831-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052833/0001209191-18-052833-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052835/0001209191-18-052835-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052837/0001209191-18-052837-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052839/0001209191-18-052839-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052841/0001209191-18-052841-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052848/0001209191-18-052848-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052851/0001209191-18-052851-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118058332/0001209191-18-058332-index.htm
2018-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118058335/0001209191-18-058335-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006200/0001209191-19-006200-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006201/0001209191-19-006201-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006202/0001209191-19-006202-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006203/0001209191-19-006203-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006204/0001209191-19-006204-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006206/0001209191-19-006206-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006208/0001209191-19-006208-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119010244/0001209191-19-010244-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038094/0001209191-19-038094-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038097/0001209191-19-038097-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038100/0001209191-19-038100-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038101/0001209191-19-038101-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038102/0001209191-19-038102-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038103/0001209191-19-038103-index.htm
2019-06-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119039122/0001209191-19-039122-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119039123/0001209191-19-039123-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119047755/0001209191-19-047755-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119048831/0001209191-19-048831-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051116/0001209191-19-051116-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051117/0001209191-19-051117-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051118/0001209191-19-051118-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051122/0001209191-19-051122-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051124/0001209191-19-051124-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119054572/0001209191-19-054572-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119058353/0001209191-19-058353-index.htm
2019-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119062036/0001209191-19-062036-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120002565/0001209191-20-002565-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120002569/0001209191-20-002569-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005159/0001209191-20-005159-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005798/0001209191-20-005798-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005806/0001209191-20-005806-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005808/0001209191-20-005808-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005810/0001209191-20-005810-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005812/0001209191-20-005812-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005814/0001209191-20-005814-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120013478/0001209191-20-013478-index.htm
2020-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120021438/0001209191-20-021438-index.htm
2020-04-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120029243/0001209191-20-029243-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120029244/0001209191-20-029244-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120029246/0001209191-20-029246-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120032414/0001209191-20-032414-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035026/0001209191-20-035026-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035027/0001209191-20-035027-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035028/0001209191-20-035028-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035030/0001209191-20-035030-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035036/0001209191-20-035036-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035037/0001209191-20-035037-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035058/0001209191-20-035058-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120043857/0001209191-20-043857-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120047981/0001209191-20-047981-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120048538/0001209191-20-048538-index.htm
2020-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120050511/0001209191-20-050511-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120051490/0001209191-20-051490-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052243/0001209191-20-052243-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052244/0001209191-20-052244-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052245/0001209191-20-052245-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052247/0001209191-20-052247-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052248/0001209191-20-052248-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120054025/0001209191-20-054025-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000141588918001458/0001415889-18-001458-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459018029555/0001564590-18-029555-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1382101/000156459019010253/0001564590-19-010253-index.htm
2019-04-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1382101/000156459019010261/0001564590-19-010261-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019010338/0001564590-19-010338-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1382101/000156459019013160/0001564590-19-013160-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1382101/000156459019013167/0001564590-19-013167-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019016067/0001564590-19-016067-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459019019236/0001564590-19-019236-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019019255/0001564590-19-019255-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019022125/0001564590-19-022125-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019022611/0001564590-19-022611-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019023255/0001564590-19-023255-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459019031883/0001564590-19-031883-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019031936/0001564590-19-031936-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019038415/0001564590-19-038415-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459019041909/0001564590-19-041909-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019042019/0001564590-19-042019-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020000514/0001564590-20-000514-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020008232/0001564590-20-008232-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1382101/000156459020010890/0001564590-20-010890-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020010955/0001564590-20-010955-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1382101/000156459020011175/0001564590-20-011175-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1382101/000156459020018532/0001564590-20-018532-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020018684/0001564590-20-018684-index.htm
2020-05-0410-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1382101/000156459020020872/0001564590-20-020872-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459020023689/0001564590-20-023689-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020024242/0001564590-20-024242-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020024736/0001564590-20-024736-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020028506/0001564590-20-028506-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020029235/0001564590-20-029235-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459020036997/0001564590-20-036997-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020037231/0001564590-20-037231-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020042563/0001564590-20-042563-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020043014/0001564590-20-043014-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459020050755/0001564590-20-050755-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020050851/0001564590-20-050851-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000158064219000779/0001580642-19-000779-index.htm
2019-10-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1382101/999999999519002305/9999999995-19-002305-index.htm

Sutro Biopharma, Inc (STRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sutro Biopharma, Inc (STRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1111%
Institutional Ownership: 8844%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-26WILLIAM J NEWELLCEOBuy25,252.00119,337.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051124/0001209191-19-051124-index.htm
2020-05-14ARTURO MD MOLINAChief Medical OfficerBuy6,451.007.7549,995.2512,083.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120029244/0001209191-20-029244-index.htm
2020-09-25EDWARD C ALBINICFO and SecretaryBuy7,174.0013,556.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052243/0001209191-20-052243-index.htm
2020-09-25Anik ShabbirChief Technical Ops. OfficerBuy8,609.0014,241.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052244/0001209191-20-052244-index.htm
2020-08-19John Gordon FreundDirectorSell500,000.008.724,360,000.001,460,053.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120047981/0001209191-20-047981-index.htm
2020-09-25LINDA A FITZPATRICKChief People & Comm. OfficerBuy7,576.0016,583.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052245/0001209191-20-052245-index.htm
2020-05-14WILLIAM J NEWELLCEOBuy64,516.007.75499,999.00166,627.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120029246/0001209191-20-029246-index.htm
2020-08-26Trevor HallamChief Scientific OfficerSell975.009.048,818.2916,790.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120048538/0001209191-20-048538-index.htm
2020-07-27Trevor HallamChief Science OfficerSell975.008.067,858.2117,765.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120043857/0001209191-20-043857-index.htm
2020-06-26Trevor HallamChief Science OfficerSell975.008.027,817.6518,740.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm
2020-09-25WILLIAM J NEWELLCEOBuy25,252.00191,879.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052248/0001209191-20-052248-index.htm
2018-10-01Daniel H PetreeDirectorSell122.0015.001,830.00192.00https://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm
2020-05-26Trevor HallamChief Science OfficerSell975.0010.009,753.3219,715.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120032414/0001209191-20-032414-index.htm
2020-04-27Trevor HallamChief Science OfficerSell2.0011.1922.3820,690.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm
2020-09-25ARTURO MD MOLINAChief Medical OfficerBuy8,609.0020,692.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052247/0001209191-20-052247-index.htm
2020-04-27Trevor HallamChief Science OfficerSell973.009.419,160.5020,692.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm
2020-03-26Trevor HallamChief Science OfficerSell975.009.699,452.5321,665.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120021438/0001209191-20-021438-index.htm
2020-02-26Trevor HallamChief Science OfficerSell975.0010.4710,207.2822,640.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120013478/0001209191-20-013478-index.htm
2020-01-27Trevor HallamChief Science OfficerSell975.0010.5110,250.3723,615.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120005159/0001209191-20-005159-index.htm
2019-12-26Trevor HallamChief Science OfficerSell975.0011.0810,802.2224,590.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119062036/0001209191-19-062036-index.htm
2019-11-26Trevor HallamChief Science OfficerSell975.0010.6810,410.2725,565.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119058353/0001209191-19-058353-index.htm
2019-10-28Trevor HallamChief Science OfficerSell975.009.989,726.1126,540.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119054572/0001209191-19-054572-index.htm
2019-09-26Trevor HallamChief Science OfficerBuy11,019.0026,819.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm
2018-10-01Merck & Co., Inc.10% Share HolderBuy666,666.0015.009,999,990.002,723,509.00https://www.sec.gov/Archives/edgar/data/1382101/000110465918059933/0001104659-18-059933-index.htm
2020-09-28Trevor HallamChief Scientific OfficerSell975.0010.2610,006.7227,530.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2020-09-25Trevor HallamChief Scientific OfficerBuy11,019.0027,809.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2019-09-26Trevor HallamChief Science OfficerBuy6,887.0029,896.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm
2019-02-12Daniel H PetreeDirectorBuy3,030.005.0915,422.703,030.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119010244/0001209191-19-010244-index.htm
2020-09-25Trevor HallamChief Scientific OfficerBuy6,887.0030,886.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2018-10-01Daniel H PetreeDirectorBuy314.005.811,824.34314.00https://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm
2020-10-05Trevor HallamChief Scientific OfficerBuy9,182.004.3640,033.5236,712.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120054025/0001209191-20-054025-index.htm
2020-11-05Trevor HallamChief Scientific OfficerSell16,751.0015.00251,265.0036,712.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm
2019-09-06Daniel H PetreeDirectorBuy826.005.094,204.343,856.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119048831/0001209191-19-048831-index.htm
2020-11-05Trevor HallamChief Scientific OfficerBuy16,751.004.3673,034.3653,463.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm
2020-09-18John Gordon FreundDirectorSell400,000.0012.004,800,000.00560,053.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120051490/0001209191-20-051490-index.htm
2019-08-29LINDA A FITZPATRICKChief People & Comm. OfficerBuy826.005.094,204.34826.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119047755/0001209191-19-047755-index.htm
2019-09-26LINDA A FITZPATRICKChief People & Comm. OfficerBuy7,575.008,401.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051118/0001209191-19-051118-index.htm
2019-09-26Anik ShabbirChief Technical Ops. OfficerBuy8,608.008,608.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051117/0001209191-19-051117-index.htm
2019-09-26ARTURO MD MOLINAChief Medical OfficerBuy8,608.008,608.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051122/0001209191-19-051122-index.htm
2019-09-26EDWARD C ALBINICFO and SecretaryBuy7,174.008,862.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051116/0001209191-19-051116-index.htm
2020-05-14LINDA A FITZPATRICKChief People & Comm. OfficerBuy3,225.007.7524,993.759,007.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120029243/0001209191-20-029243-index.htm
2020-09-11John Gordon FreundDirectorSell500,000.0010.005,000,000.00960,053.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120050511/0001209191-20-050511-index.htm